Chimin(SH:603222) Zheng Quan Shi Bao Wang·2025-09-05 09:59Core Viewpoint - Jimin Health (603222) experienced a significant decline of 8.77% in its stock price, with a trading volume of 9.47 billion yuan and a turnover rate of 17.07% on the day of the report [1][2]. Trading Activity - The stock was listed on the Shanghai Stock Exchange's watch list due to a daily price deviation of -10.01%, with a total net sell of 76.36 million yuan from brokerage seats [2]. - The top five brokerage seats accounted for a total transaction volume of 171 million yuan, with buying amounting to 47.21 million yuan and selling at 124 million yuan, resulting in a net sell of 76.36 million yuan [2]. - The largest buying brokerage was Guosen Securities, Shenzhen, with a purchase amount of 10.28 million yuan, while the largest selling brokerage was Guotai Junan Securities, with a sell amount of 41.93 million yuan [2]. Stock Performance and Fund Flow - Over the past six months, the stock has appeared on the watch list 11 times, with an average price increase of 1.50% the day after being listed and an average increase of 5.91% in the following five days [3]. - On the day of the report, the stock saw a net outflow of 9.61 million yuan in principal funds, with a significant outflow of 10.44 million yuan from large orders, while smaller orders saw a net inflow of 835,000 yuan [3]. - In the past five days, the total net outflow of principal funds reached 69.01 million yuan [3]. Financial Performance - According to the semi-annual report released on August 21, the company achieved a revenue of 366 million yuan in the first half of the year, representing a year-on-year decline of 21.30%, and reported a net loss of 52.70 million yuan [4].